Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Peter, Jantscheff"'
Autor:
Gerd Bendas, Ulrich Massing, Dieter O. Fürst, Gregor Kirfel, Ralph Graeser, Lenka A. Taylor, Juliane Fritzsche, Martin Schlesinger, Peter Jantscheff
Supplementary Figure 4 from Lysophosphatidylcholine Pretreatment Reduces VLA-4 and P-Selectin–Mediated B16.F10 Melanoma Cell Adhesion In vitro and Inhibits Metastasis-Like Lung Invasion In vivo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00f69d327d03e575bced0222a4e83cd4
https://doi.org/10.1158/1535-7163.22482407
https://doi.org/10.1158/1535-7163.22482407
Autor:
Gerd Bendas, Ulrich Massing, Dieter O. Fürst, Gregor Kirfel, Ralph Graeser, Lenka A. Taylor, Juliane Fritzsche, Martin Schlesinger, Peter Jantscheff
Supplementary Figure 5 from Lysophosphatidylcholine Pretreatment Reduces VLA-4 and P-Selectin–Mediated B16.F10 Melanoma Cell Adhesion In vitro and Inhibits Metastasis-Like Lung Invasion In vivo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52190d0f6f323bfc0a6f391d40a5b44a
https://doi.org/10.1158/1535-7163.22482404
https://doi.org/10.1158/1535-7163.22482404
Autor:
Gerd Bendas, Ulrich Massing, Dieter O. Fürst, Gregor Kirfel, Ralph Graeser, Lenka A. Taylor, Juliane Fritzsche, Martin Schlesinger, Peter Jantscheff
Supplementary Figure 3 from Lysophosphatidylcholine Pretreatment Reduces VLA-4 and P-Selectin–Mediated B16.F10 Melanoma Cell Adhesion In vitro and Inhibits Metastasis-Like Lung Invasion In vivo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cac2a8e38a921faa01fb63774ba5043
https://doi.org/10.1158/1535-7163.22482410
https://doi.org/10.1158/1535-7163.22482410
Autor:
Gerd Bendas, Ulrich Massing, Dieter O. Fürst, Gregor Kirfel, Ralph Graeser, Lenka A. Taylor, Juliane Fritzsche, Martin Schlesinger, Peter Jantscheff
Supplementary Figure 1A from Lysophosphatidylcholine Pretreatment Reduces VLA-4 and P-Selectin–Mediated B16.F10 Melanoma Cell Adhesion In vitro and Inhibits Metastasis-Like Lung Invasion In vivo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2370bf3e7cfa51750e6b22afd3c13c9a
https://doi.org/10.1158/1535-7163.22482416
https://doi.org/10.1158/1535-7163.22482416
Autor:
Gerd Bendas, Ulrich Massing, Dieter O. Fürst, Gregor Kirfel, Ralph Graeser, Lenka A. Taylor, Juliane Fritzsche, Martin Schlesinger, Peter Jantscheff
Lysophosphatidylcholine (LysoPC) is an important intermediate in degradation and biosynthesis of phosphatidylcholine (PC). Reduced plasma LysoPC levels observed in patients with advanced cancer indicate a deregulation of LysoPC metabolism in metastas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53084f319efdffddae4583c7cbb00cdc
https://doi.org/10.1158/1535-7163.c.6530918.v1
https://doi.org/10.1158/1535-7163.c.6530918.v1
Autor:
Gerd Bendas, Ulrich Massing, Dieter O. Fürst, Gregor Kirfel, Ralph Graeser, Lenka A. Taylor, Juliane Fritzsche, Martin Schlesinger, Peter Jantscheff
Supplementary Figure 2 from Lysophosphatidylcholine Pretreatment Reduces VLA-4 and P-Selectin–Mediated B16.F10 Melanoma Cell Adhesion In vitro and Inhibits Metastasis-Like Lung Invasion In vivo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f75d1138636667781a919e238b4dd60
https://doi.org/10.1158/1535-7163.22482413.v1
https://doi.org/10.1158/1535-7163.22482413.v1
Autor:
Janette Beshay, Peter Jantscheff, Holger Weber, Christoph Schächtele, Cynthia Obodozie, Thomas Lemarchand
Publikováno v:
Cancers
Volume 11
Issue 2
Cancers, Vol 11, Iss 2, p 242 (2019)
Volume 11
Issue 2
Cancers, Vol 11, Iss 2, p 242 (2019)
In this second study, we established syngeneic in vivo models named carcinogen-induced mouse-derived isografts (cMDIs). Carcinogen-induced tumors were obtained during short-term observation (3&ndash
9 months) of CBA/J mice treated with various a
9 months) of CBA/J mice treated with various a
Autor:
Janette Beshay, Holger Weber, Peter Jantscheff, Cynthia Obodozie, Thomas Lemarchand, Christoph Schächtele
Publikováno v:
Cancers, Vol 11, Iss 2, p 244 (2019)
Cancers
Volume 11
Issue 2
Cancers
Volume 11
Issue 2
Syngeneic in vivo tumor models are valuable for the development and investigation of immune-modulating anti-cancer drugs. In the present study, we established a novel syngeneic in vivo model type named mouse-derived isografts (MDIs). Spontaneous MDIs
Gene and immunotherapeutic approaches to treat human malignant tumors are reviewed. Special attention is given to the different strategies of cancer gene therapy and to recent aspects of cytokine-supported tumor immunotherapy or tumor-specific vaccin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a303f79b0fa9ce84dc00148c7c27bd2
http://doc.rero.ch/record/310207/files/262_2007_Article_BF02785840.pdf
http://doc.rero.ch/record/310207/files/262_2007_Article_BF02785840.pdf
Autor:
Ulrich Massing, Peter Jantscheff
Many of the most serious diseases are caused by gene defects. A very important example is cancer, having its origin in a cascade of acquired gene defects (1,2). Others are the result of inherited, mostly single-gene defects, and a prominent example i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::753484c6cff21dffc8bdf627550e1adb
https://doi.org/10.1201/9780849397271-19
https://doi.org/10.1201/9780849397271-19